Drug industry studies promote expanded uses for Gardasil vaccine
A recent study, funded by Merck Research Laboratories, a division of Merck & Company, which manufactures and markets the Gardasil vaccine, is touting the drug for use not only as protection against cervical cancer, but also to prevent genital warts and other low-grade cervical growths. The study uses its findings to also promote expansion of the drug’s target market to include boys and young men. Previously, the drug has been targeted at girls beginning at age 9.